(Q43633456)

25 November 2017

title

Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia (English)

1 reference

25 November 2017

López A

1

1 reference

25 November 2017

de la Rubia J

2

1 reference

25 November 2017

Martín G

3

1 reference

25 November 2017

Martínez J

4

1 reference

25 November 2017

Cervera J

5

1 reference

25 November 2017

Jarque I

6

1 reference

25 November 2017

Sempere A

7

1 reference

25 November 2017

Plumé G

8

1 reference

25 November 2017

Saavedra S

9

1 reference

25 November 2017

Regadera A

10

1 reference

25 November 2017

Sanz G

11

1 reference

25 November 2017

Gomis F

12

1 reference

25 November 2017

Pérez-Sirvent ML

13

1 reference

25 November 2017

Senent L

14

1 reference

25 November 2017

Jiménez C

15

1 reference

25 November 2017

Sanz MA

16

1 reference

25 November 2017

publication date

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

25

1 reference

25 November 2017

issue

8

1 reference

25 November 2017

page(s)

685-692

1 reference

Population-based age- and sex-specific incidence rates in the 4 main types of leukaemia.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Improved survival for patients with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Acute Myeloblasts Leukemia with Minimal Myeloid Differentiation (FAB AML-M0): A Study of Eleven Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

A rapid banding technique for human chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organiz

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Validation of a model to predict survival in elderly patients with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Acute myeloid leukaemia in the elderly: biology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900006-6

7 January 2021

10.1016/S0145-2126(01)00006-6

Identifiers

DOI

1 reference

25 November 2017

1 reference